medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2024-10-43-47medalphabet-3791Research ArticleСтатьиАутотрансплантация почки у пациентки с артериитом Такаясу с поражением почечных артерийKidney autotransplantation with renal arteries injury in a patient with Takayasu arteritishttps://orcid.org/0000-0002-5636-5928БородинаИ. Э.BorodinaI. E.

Бородина Ирина Эдуардовна, врач-ревматолог, терапевт, клинический ординатор кафедры госпитальной терапии и скорой медицинской помощи

Екатеринбург

Borodina Irina E., rheumatologist, therapist, clinical resident at Dept of Hospital Therapy and Emergency Medical Care 

Ekaterinburg

borodysik@mail.ruhttps://orcid.org/0000-0001-6216-2468ПоповА. А.PopovA. A.

Попов Артем Анатольевич, д.м.н., зав. кафедрой госпитальной терапии и скорой медицинской помощи

Екатеринбург

Popov Artem A., DM Sci (habil.), head of Dept of Hospital Therapy and Emergency Medical Care 

Ekaterinburg

https://orcid.org/0000-0002-2478-6971ФадинБ. В.FadinB. V.

Фадин Борис Васильевич, д.м.н., зав. отделением сосудистой хирургии 

Екатеринбург

Fadin Boris V., DM Sci (habil.), head of Dept of Vascular Surgery 

Ekaterinburg

https://orcid.org/0000-0003-1833-6680РжанниковВ. В.RzhannikovV. V.

Ржанников Виталий Валерьевич, врач сердечно-сосудистый хирург 

Екатеринбург

Rzhannikov Vitaly V., cardiovascular surgeon 

Ekaterinburg

https://orcid.org/0000-0001-7481-2528АгеевА. Н.AgeevA. N.

Агеев Артем Никифорович, к.м.н., ассистент кафедры онкологии и лучевой диагностики, врач-рентгенолог 

Екатеринбург

Ageev Artem N., PhD Med, assistant at Dept of Oncology and Radiation Diagnostics, radiologis 

Ekaterinburg

https://orcid.org/0000-0003-3720-9193ШардинаЛ. А.ShardinaL. A.

Шардина Любовь Андреевна, д.м.н., профессор кафедры высшего сестринского и социального образования 

Екатеринбург

Shardina Lyubov A., DM Sci (habil.), professor at Dept of Higher Nursing and Social Education 

Ekaterinburg

ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России ; ГАУЗ СО «Cвердловская областная клиническая больница № 1»РоссияUral State Medical University ; Sverdlovsk Regional Clinical Hospital No. 1Russian FederationФГБОУ ВО «Уральский государственный медицинский университет» Минздрава РоссииРоссияUral State Medical UniversityRussian FederationГАУЗ СО «Cвердловская областная клиническая больница № 1»РоссияSverdlovsk Regional Clinical Hospital No. 1Russian Federation202422072024110Ревматология в общей врачебной практике (1)4347Copyright © Бородина И.Э., Попов А.А., Фадин Б.В., Ржанников В.В., Агеев А.Н., Шардина Л.А., 20242024Бородина И.Э., Попов А.А., Фадин Б.В., Ржанников В.В., Агеев А.Н., Шардина Л.А.Borodina I.E., Popov A.A., Fadin B.V., Rzhannikov V.V., Ageev A.N., Shardina L.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3791

Артериит Такаясу (АТ) – системный васкулит, развивающийся, как правило, у пациентов моложе 50 лет с преимущественным поражением аорты и/или ее главных ветвей. В статье описывается клинический случай пациентки с двусторонним поражением почечных артерий, вызванных АТ, которой была проведена аутотрансплантация почки. Первые проявления псориаза у пациентки возникли после психологического стресса спустя 15 лет после оперативного вмешательства. Описанное клиническое наблюдение многоэтапного хирургического лечения артериита Такаясу, закончившегося благоприятно, представлено нами с целью демонстрации возможностей современных медицинских технологий как в диагностике, так и в оперативном лечении многососудистого поражения при артериите Такаясу. Сочетание АТ и псориаза – редкая патология, проблемы диагностики и лечения которой требуют дальнейшего изучения.

Takayasu arteritis (AT) is a systemic vasculitis of large vessels. As a rule, AT develops in patients under 50 years of age and is characterized by vasculitis, often granulomatous, with a predominant lesion of the aorta and/or its main branches. The article describes a clinical case of a patient with bilateral lesions of the renal arteries caused by AT, who underwent kidney autotransplantation. The first manifestations of psoriasis in the patient occurred after psychological stress 15 years after surgery. The described clinical observation of multi-stage surgical treatment of Takayasu arteritis, which ended favorably, is presented by us in order to demonstrate the capabilities of modern medical technologies in both diagnosis and surgical treatment of multi-vessel lesions in Takayasu arteritis. The combination of AT and psoriasis is a rare pathology, the problems of diagnosis and treatment of which require further study.

артериит Такаясуаутотрансплантация почкипсориазTakayasu arteritiskidney autotransplantationpsoriasisReferencesНасонов, Е. Л. Ревматология: национальное руководство / Е. Л. Насонов, В. А. Насонова. Москва: ГЭОТАР-Медиа, 2010: 539–567.Nasonov E.L., Nasonova V.A. Revmatologiya. Nacional’noe rukovodstvo [Rheumatology. National guidelines]. Moscow: Geotar- Media, 2010: 539–567 (In Russ.).Kocabay G. et al. Takayasu arteritis associated with systemic sclerosis. Mod. Rheumatol. 2006; 16 (2): 120–121. https://doi.org/10.1007/s10165–006–0459–5Kocabay G. et al. Takayasu arteritis associated with systemic sclerosis. Mod. Rheumatol. 2006; 16 (2): 120–121. https://doi.org/10.1007/s10165–006–0459–5Баткаева, Н.В. Разнообразие коморбидной патологии у больных псориазом тяжелого течения / Н. В. Баткаева, Т. В. Коротаева, Э. А. Баткаев. Альманах клинической медицины. 2018. № 46 (1). С. 76–81. https://doi.org/10.18786/2072–0505–2018–46–1–76–81Batkaeva N. V., Korotaeva T. V., Batkaev E. A. Multiplicity of comorbidities in patients with severe psoriasis. Almanac of Clinical Medicine. 2018;46(1):76–81. (In Russ.) https://doi.org/10.18786/2072–0505–2018–46–1–76–81.Armstrong A. W., et al. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013; 149 (1): 84–91. https://doi.org/10.1001/2013.jamadermatol.406Armstrong A. W., et al. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013; 149 (1): 84–91. https://doi.org/10.1001/2013.jamadermatol.406Rocha L. K., et al. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis. Journal of Rheumatology. 2013; 40 (5): 734–738. https://doi.org/10.3899/jrheum.121276Rocha L. K., et al. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis. Journal of Rheumatology. 2013; 40 (5): 734–738. https://doi.org/10.3899/jrheum.121276Kimura A., et al. Comprehensive analysis of HLA genes in Takayasu arteritis in Japan. Int. J. Cardiol. 1996; 54: 61–69. https://doi.org/10.1016/s0167–5273(96)88774–2Kimura A., et al. Comprehensive analysis of HLA genes in Takayasu arteritis in Japan. Int. J. Cardiol. 1996; 54: 61–69. https://doi.org/10.1016/s0167–5273(96)88774–2Weyand C. M., et al. Medium- and large-vessel vasculitis. N. Engl. J. Med. 2003; 349:160–169. https://doi.org/10.1056/NEJMra022694Weyand C. M., et al. Medium- and large-vessel vasculitis. N. Engl. J. Med. 2003; 349:160–169. https://doi.org/10.1056/NEJMra022694Cargill M., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 2007; 80: 273–290. https://doi.org/10.1086/511051Cargill M., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 2007; 80: 273–290. https://doi.org/10.1086/511051Terao C. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. American Journal of Human Genetics. 2013; 93 (2): 289–297. https://doi.org/10.1016/j.ajhg.2013.05.024.Terao C. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. American Journal of Human Genetics. 2013; 93 (2): 289–297. https://doi.org/10.1016/j.ajhg.2013.05.024.Schackman R, Dempster WY. Surgical kidney. A case demonstrated at the Post-Graduate Medical School of London. Br med J. 1924 i.v., (1963).Schackman R, Dempster WY. Surgical kidney. A case demonstrated at the Post-Graduate Medical School of London. Br med J. 1924 i.v., (1963).Арзуманов С.В., Поляков Н.В., Рябов А.Б., Галицкая Д.А. Аутотрансплантация почки – метод лечения поражения мочеточника в урологической и онкологической практике. Вестник трансплантологии и искусственных органов. 2022; № 1: 36–47. DOI: 10.15825/1995–1191–2022–1–36–47Arzumanov, S.V., Polyakov, N.V., Ryabov A. B., Galitskaya, D. A. Kidney autotransplantation is a method of treating ureteral lesions in urological and oncological practice. Bulletin of transplantology and artificial organs. 2022; 1: 36–47. DOI: 10.15825/1995–1191–2022–1–36–47Zhang H, Li F, Ren H, Zheng Y. Aortic bypass and orthotopic right renal autotransplantation for midaortic syndrome: a case report. BMC Surg. 2014; 14 (1): 86. doi.org/ 10.1186/1471–2482–14–86 e-mail: medalfavit@mail.ru47Zhang H, Li F, Ren H, Zheng Y. Aortic bypass and orthotopic right renal autotransplantation for midaortic syndrome: a case report. BMC Surg. 2014; 14 (1): 86. DOI: 10.1186/1471–2482–14–86 e-mail: medalfavit@mail.ru47Mekik Akar E, Aydın F, Tüzüner A, Fitöz S, Öztürk S, Kurt Şükür ED, Şanlıdilek U, Çelikel E, Özçakar ZB, Çakar N, Yalçınkaya F. Renal Autotransplantation in a Patient with Bilateral Renal Artery Stenosis Secondary to Takayasu Arteritis. Int J Organ Transplant Med. 2020; 11 (1): 37–41.Mekik Akar E, Aydın F, Tüzüner A, Fitöz S, Öztürk S, Kurt Şükür ED, Şanlıdilek U, Çelikel E, Özçakar ZB, Çakar N, Yalçınkaya F. Renal Autotransplantation in a Patient with Bilateral Renal Artery Stenosis Secondary to Takayasu Arteritis. Int J Organ Transplant Med. 2020; 11 (1): 37–41.Brailovski E, Steinmetz OK, Weber CL. Renal artery reconstruction and kidney autotransplantation for Takayasu arteritis-induced renal artery stenosis. J Vasc Surg Cases Innov Tech. 2019 Apr 30;5(2):156–159. DOI: 10.1016/j.jvscit.2018.10.010Brailovski E, Steinmetz OK, Weber CL. Renal artery reconstruction and kidney autotransplantation for Takayasu arteritis-induced renal artery stenosis. J Vasc Surg Cases Innov Tech. 2019 Apr 30;5(2):156–159. DOI: 10.1016/j.jvscit.2018.10.010Saadoun D, et al. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol. 2015; 67 (5):1353–1360. https://doi.org/10.1002/art.39037.Saadoun D, et al. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol. 2015; 67 (5):1353–1360. https://doi.org/10.1002/art.39037.Savioli B, et al. Are cytokines and chemokines suitable biomarkers for Takayasu arteritis? Autoimmun Rev. 2017; 16 (10): 1071–1078. https://doi.org/10.1016/j.autrev.2017.07.023Savioli B, et al. Are cytokines and chemokines suitable biomarkers for Takayasu arteritis? Autoimmun Rev. 2017; 16 (10): 1071–1078. https://doi.org/10.1016/j.autrev.2017.07.023Terao C, et al. Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis. Proc. Natl. Acad. Sci. USA. 2018; 115 (51): 13045–13050. https://doi.org/10.1073/pnas.1808850115. Epub 2018 Nov 29Terao C, et al. Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis. Proc. Natl. Acad. Sci. USA. 2018; 115 (51): 13045–13050. https://doi.org/10.1073/pnas.1808850115. Epub 2018 Nov 29Vidal C, et al. A polymorphism within the psoriasis susceptibility 1 candidate 1 (PSORS 1C 1) gene is not linked to HLA-B*58:01 in an Australia. cohort& Drug Metab. Pharmacokinet. 2016; 31 (3): 252–255. https://doi.org/10.1016/j.dmpk.2015.08.007Vidal C, et al. A polymorphism within the psoriasis susceptibility 1 candidate 1 (PSORS 1C 1) gene is not linked to HLA-B*58:01 in an Australia. cohort& Drug Metab. Pharmacokinet. 2016; 31 (3): 252–255. https://doi.org/10.1016/j.dmpk.2015.08.007Fukuhara K, et al. Psoriatic arthritis associated with dilated cardiomyopathy and Takayasu’s arteritis. The British Journal of Dermatology.– 1998; 138 (2): 329–333. https://doi.org/10.1046/j.1365–2133.1998.02085.x PMID: 9602885Fukuhara K, et al. Psoriatic arthritis associated with dilated cardiomyopathy and Takayasu’s arteritis. The British Journal of Dermatology.– 1998; 138 (2): 329–333. https://doi.org/10.1046/j.1365–2133.1998.02085.x PMID: 9602885Westphal, D. C. Generalized pustular psoriasis induced by systemic steroid dose reduction. An Bras Dermatol. 2016; № 91 (5): 664–666. https://doi.org/10.1590/abd1806–4841.20163804Westphal, D. C. Generalized pustular psoriasis induced by systemic steroid dose reduction. An Bras Dermatol. 2016; № 91 (5): 664–666. https://doi.org/10.1590/abd1806–4841.20163804Singh, G.K. Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: two challenging cases. Indian J. Dermatol. 2015; 60 (2):194–197. https:// doi.org/ 10.4103/0019-5154.152529Singh, G.K. Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: two challenging cases. Indian J. Dermatol. 2015; 60 (2):194–197. https:// doi.org/ 10.4103/0019-5154.152529The European Medicines Agency (EMA) [Электронный ресурс] URL: https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-tremfya_en.pdf Дата обращения 22.03.2024.The European Medicines Agency (EMA) [Электронный ресурс] URL:Langley R.G., Tsai T.F., Flavin S., Song M., Randazzo B., Wasfi Y. et al. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, doubleblind, phase III NAVIGATE trial. Br. J. Dermatol. 2018; 178(1): 114–123. https://doi.org/10.1111/bjd.15750https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-tremfya_en.pdf Дата обращения 22.03.2024.Reich K, Armstrong A.W, Langley R.G, et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019; 394 (10201): 831–839. 394. 10.1016/S0140-6736(19)31773–8.Langley R.G., Tsai T.F., Flavin S., Song M., Randazzo B., Wasfi Y. et al. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, doubleblind, phase III NAVIGATE trial. Br. J. Dermatol. 2018; 178(1): 114–123. https://doi.org/10.1111/bjd.15750Reich K, Armstrong A.W, Langley R.G, et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019; 394 (10201): 831–839. 394. 10.1016/S0140-6736(19)31773–8.Reich K, Armstrong A.W, Langley R.G, et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019; 394 (10201): 831–839. 394. 10.1016/S0140-6736(19)31773–8.

The authors declare that there are no conflicts of interest present.